April 2020

CJEU judgment in Case C-650/17 Royalty Pharma
Europe’s highest court restricts the types of patents that can be used as the basis for SPCs
Read More
30
Apr
2020
Is an injunction always appropriate?
Public interest is at the heart of the matter
Read More
28
Apr
2020
World IP Day 2020
Innovate for a Green Future
Read More
24
Apr
2020
Update on G 4/19 – Enlarged board of appeal referral on double patenting
The referring Board’s written decision sheds further light on the points of law to be considered by the Enlarged Board and the referral’s possible implications
Read More
24
Apr
2020
EPO begins running opposition oral proceedings by video conference
Carpmaels & Ransford is involved in one of the first video conference inter partes hearings
Read More
23
Apr
2020
Covid-19: Impact on trade marks and designs
UKIPO and EUIPO introduce period of adjustment during Covid-19
Read More
17
Apr
2020
Covid-19: Effects on UK IP litigation
Key features of the new guidance for IP litigation
Read More
17
Apr
2020
Plausibility at the EPO – good news for innovators?
In a welcome decision for patentees, an EPO pharmaceutical Board of Appeal establishes plausibility on the basis of the prior art, confirming that plausibility and obviousness are different tests
Read More
14
Apr
2020
The EPO plans to require parties to attend hearings by videoconference
Examining Division oral proceedings will now be held by videoconference unless there are exceptional reasons for the hearing to be conducted in person
Read More
02
Apr
2020

Type

Service

Sector

Archive